Form 4 for BDTX Black Diamond Therapeutics, Inc.
Accepted 2024-12-16 00:00:00 ET · period of report 2024-12-13 · accession 0000950170-24-136739 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-12-16 | 2024-12-13 | BDTX | Behbahani Ali | Dir | A - Grant | $2.50 | +5,750 | 63.3K | +10% | +$14.4K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-12-13 | A | A | 5,750 | $2.50 | 63,334 | D | — | — | (F2) The price reported in Column 4 is based upon the closing market price of the Issuer's common stock on December 12, 2024. |